Minireview: Delivering the Code: Polyplex Carriers for Deoxyribonucleic Acid and Ribonucleic Acid Interference Therapies

Author:

Christie R. James1,Nishiyama N.23,Kataoka K.1243

Affiliation:

1. Department of Materials Engineering (R.J.C., K.K.), University of Tokyo, Tokyo 113-8656, Japan;

2. Center for Disease Biology and Integrative Medicine (N.N., K.K.), Graduate School of Medicine, University of Tokyo, Tokyo 113-0033, Japan;

3. Graduate School of Engineering and Center for NanoBio Integration (N.N., K.K.), University of Tokyo, Tokyo 113-8656, Japan;

4. Core Research for Evolutional Science and Technology (K.K.), Japan Science and Technology Agency, Saitama 332-0012, Japan

Abstract

Nucleic acid-based therapies offer great potential for treatment of a variety of diseases including cancer by modulating protein expression with DNA or small interfering RNA. However, realization of their full therapeutic potential is currently limited due to an inability to reach the target site in an active form. Identification of delivery barriers such as stability in circulation, resistance to degradation and entrapment in subcellular vesicles has led to development of sophisticated multifunctional synthetic polymers for forming ionic complexes with nucleic acids and also providing performance-enhancing features. The most promising designs comprise features to help increase stability in circulation and also contain functionality to aid in endosome escape of nucleic acid cargo after cellular internalization.

Publisher

The Endocrine Society

Subject

Endocrinology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3